⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Edelweiss Recently Listed IPO Fund - Growth - Direct Plan | Kotak Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Edelweiss MF | Kotak MF |
| Category | Equity - Thematic Fund - Other | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹34.14 (30 Oct 2026) | ₹17.44 (30 Oct 2026) |
| Rating | ★★★★ | ★★★ |
| Benchmark | India Recent 100 IPO Index | Nifty Healthcare Index - TRI |
| Fund Manager | Bhavesh Jain | Dhananjay Tikariha |
| Inception | 22 Feb 2018 | 11 Dec 2023 |
| Returns | ||
| 1Y | 14.82% | 23.31% |
| 3Y | 16.49% | — |
| 5Y | 10.64% | — |
| Since Inception | 15.17% | 21.25% |
| Risk | ||
| 18.67 | 14.88 | |
| 0.91 | 0.99 | |
| 0.60 | 1.02 | |
| 10.76 | 3.82 | |
| 1.11 | 2.12 | |
| -15.57% | -11.03% | |
| Costs | ||
| Expense Ratio | 1.13% | 1.04% |
| Exit Load | 2% upto 180D, Nil after 180D | 0.50% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Edelweiss MF98%
Kotak MF98%
2.2%Only 2.2% of holdings by weight are common between Edelweiss MF and Kotak MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingEdelweiss MFKotak MF
Prasol Chemicals Ltd.2.50%2.24%
Category context: Equity vs Equity. Open the full Screener →